Investigation of depot neuroleptic injection site reactions
Authors:
- Julie C. JonesJJJulie C. Jones
- Jennifer C. DayJDJennifer C. Day
- John R. TaylorJTJohn R. Taylor
- Christopher S. ThomasCTChristopher S. Thomas
Open Access
- 1 October 1998
- journal article
- Published by Royal College of Psychiatrists in Psychiatric Bulletin
- Vol. 22 (10) , 605-607
Abstract
Aims and method: A cross-sectional survey was performed on 318 patients receiving depot medication. The presence or absence of a depot site reaction was recorded by psychiatric nursing staff on a standardised form.Results: Seventeen per cent of patients were found to have clinically significant depot site reactions. Such reactions were associated with increased frequency of injection and increased total volume of depot administered in the previous 12 months. The severity of a depot site reaction was unrelated to the concentration of depot preparation administered.Clinical implications: Depot site reactions may be reduced by maximising the interval between injections and using low volume (highly concentrated) preparations of depot neuroleptic medication.Keywords
This publication has 6 references indexed in Scilit:
- Complications at site of injection of depot neuroleptics: TABLE IBMJ, 1995
- Abscesses following prolonged intramuscular administration of perphenazine enantateActa Psychiatrica Scandinavica, 1980
- Probable toxic necrosis after prolonged fluspirilene administration.BMJ, 1979
- FLUPENTHIXOL DECANOATE ‐IN TREATMENT OF OUT‐PATIENTSActa Psychiatrica Scandinavica, 1974
- Dose equivalence of the anti-psychotic drugsJournal of Psychiatric Research, 1974
- Outpatient Maintenance of Chronic Schizophrenic Patients with Long-acting Fluphenazine: Double-blind PlaceboBMJ, 1973